Skip to content

Advancing addiction treatment

advancing addiction treatment using neuromodulation: a rTMS-enhanced CBT trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22620
Enrollment
80
Registered
2015-07-06
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alcohol addiction / alcohol verslaving repetitive Transcranial Magnetic Stimulation (rTMS) / repetitieve Transcraniële Magnetische Stimulatie treatment / behandeling functional Magnetic Resonance Imaging (fMRI)

Interventions

One group will receive rTMS treatment, and the other group will receive sham rTMS treatment.

Sponsors

AMC, department of psychiatry, Addiction care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Men and women. - Age between 25-65. - Recent DSM-V diagnosis (mild, moderate and severe) of alcohol use disorder (2 weeks after detox) and will be in treatment during the entire stimulation period (2 weeks after inclusion). - Sufficient speaking and understanding of Dutch language.

Exclusion criteria

Exclusion criteria: - A DSM-V diagnosis of schizophrenia or another psychotic disorder, personality disorder or sleep disorder. - TMS contraindications: history of epileptic seizures or epilepsy in a first degree relative, irregular sleep/ wake rhythm. - MR contraindications (only relevant for the 40 participants who will undergo MR scanning): metal implants, claustrophobia. - No drug use during the treatment process other than drugs prescribed by their practitioner in order to overcome their alcohol dependence. - IQ under 80 - Endocrinological disorders or regular use of corticosteroids.

Design outcomes

Primary

MeasureTime frame
The total number of abstinent days at six months follow up: See Schluter, R. S., van Holst, R. J., & Goudriaan, A. E. (2018). Repetitive transcranial magnetic stimulation (rTMS) in alcohol dependence: study protocol of a randomized controlled clinical trial of efficacy and working mechanisms. BMC psychiatry, 18(1), 1-12.

Secondary

MeasureTime frame
Secondary outcomes are changes in craving (immediately after 2-week rTMS treatment; at 3-months and at 6-months and 12-months past treatment; changes in SST, AAT (cognitive tasks), and changes in (f)MRI measures immediately after rTMS treatment

Contacts

Public ContactRenée Schluter

Academisch Medisch Centrum - Afdeling psychiatrie, PA3.225

r.s.schluter@amc.uva.nl0031645703125

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)